Ferritin Hybrid Particles for Combination Vaccines

2026-08-24

The reference study develops an Escherichia coli-produced ferritin hybrid particle that co-displays influenza A M2e and SARS-CoV-2 S-protein tandem epitopes. In mice, the construct generated stronger antigen-specific responses than antigen-only controls and showed functional activity in pseudovirus inhibition, M2-expressing cell binding, and ADCC-related assays.

1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine Control

2026-08-23

PP 3 is a practical negative control for separating Src-dependent effects from vehicle, scaffold, and pathway artifacts in kinase and vascular assays. Pairing this research use only chemical with PP 2 can clarify whether an apparent signaling phenotype is Src-linked or instead reflects L-type calcium-channel control of contraction.

AY 9944 dihydrochloride: DHCR7 Workflow

2026-08-22

Build controlled 7-dehydrocholesterol accumulation studies, membrane-raft experiments, and PBMC immune-response assays with a tunable DHCR7 inhibitor. This guide separates validated genetic evidence from practical chemical-workflow recommendations so researchers can design stronger sterol and antiviral studies.

Influenza Hemagglutinin (HA) Peptide Guide

2026-08-22

Influenza Hemagglutinin (HA) Peptide is a synthetic HA tag peptide for antibody-based detection, competitive elution, and protein purification workflows. Its defined YPYDVPDYA sequence, high reported purity, and documented solvent compatibility support reproducible immunoprecipitation and protein interaction studies.

Dovitinib (TKI-258): RTK Research Guide

2026-08-21

Dovitinib, also called TKI-258 and CHIR-258, is a multitargeted receptor tyrosine kinase inhibitor used to study FLT3, c-Kit, FGFR, VEGFR, and PDGFR signaling. Its reported nanomolar activity and downstream effects on ERK, STAT, and apoptosis pathways support research in multiple myeloma and hepatocellular carcinoma models, but they do not establish clinical efficacy.

Chemically Modified TPO mRNA Stimulates Thrombopoiesis

2026-08-20

Zhang and colleagues developed chemically modified, in-vitro-transcribed thrombopoietin mRNA and delivered it with lipid nanoparticles to increase platelet production in mice. The study links transient TPO expression with dose-dependent thrombopoiesis and rapid recovery from antibody-induced thrombocytopenia, while also illustrating the design requirements for therapeutic RNA workflows.

Amplex Red: H2O2 Detection and Assay Design

2026-08-20

Amplex Red, also known as 10-Acetyl-3,7-dihydroxyphenoxazine, is a fluorogenic hydrogen peroxide and peroxidase substrate that generates fluorescent resorufin. Its sensitivity is useful for reactive oxygen species detection, but NAD(P)H-dependent assays require controls because HRP-associated superoxide can create background signal.

Panobinostat Targets MLL-Rearranged ALL Epigenetics

2026-08-19

DHODH Inhibition in NPC: TP53-Dependent Effects

2026-08-19

Dong et al. identify pyrimidine biosynthesis and DHODH as therapeutically relevant features of nasopharyngeal carcinoma. Their combination of dataset analysis, pharmacological testing, transcriptomics, and TP53 knockdown shows that BAY2402234 suppresses NPC phenotypes through a TP53-dependent response.

NSC 87877 Workflows for Shp2 Signaling

2026-08-18

Use NSC 87877 to separate SHP2 catalytic phosphatase activity from adaptor-complex behavior in microglial, EGF–ERK, and disease-model experiments. This workflow emphasizes concentration design, orthogonal readouts, reference-study translation, and controls that prevent Shp1 activity or formulation issues from confounding interpretation.

Streptavidin-FITC in Cell Adhesion Assays

2026-08-18

Streptavidin-FITC converts biotinylated antibodies, proteins, and nucleic acid probes into a practical green-fluorescent readout for tissue imaging, cell phenotyping, and adhesion studies. This workflow-focused guide connects the product to recent ST3GAL1–sialylation research while distinguishing validated assay principles from experiment-specific recommendations.

SD 169: p38 MAPK Workflow Guide

2026-08-17

SD 169 (indole-5-carboxamide) offers a practical way to interrogate p38α/β signaling in inflammation, apoptosis, type 1 diabetes research, and nerve-injury models. This guide translates its ATP-competitive activity into assay-ready workflows while separating product-supported findings from optimization recommendations and emerging phosphatase-aware concepts.

GI Device Delivery of mRNA-LNPs in Mice and Pigs

2026-08-17

This 2024 study shows that ingestible microjet devices can deliver firefly luciferase mRNA–lipid nanoparticles into the stomach and intestinal walls of mice and minipigs. Gastrointestinal administration produced controlled release, plasma and lymph-node exposure, and route-dependent expression and biodistribution, supporting further investigation of needle-free mRNA delivery.

Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels

2026-08-16

Huang and colleagues evaluated acute and chronic sulfamonomethoxine toxicity across algae, cladocerans, and medaka, providing a cross-trophic comparison that had been limited for this aquaculture antibiotic. The results identify microalgae as particularly sensitive test organisms and support more careful assessment of antibiotic residues in aquaculture-affected waters.

Mitoxantrone: Assay Design Beyond ABCG2 Resistance

2026-08-15

Mitoxantrone is more than a cytotoxic topoisomerase II inhibitor: it is a useful mechanistic probe for separating target-mediated activity from ABCG2-driven drug efflux. This guide translates recent marein–ABCG2 findings into practical, transporter-aware oncology assay decisions.